Tools to help patients and other stakeholders' input into choice of estimand and intercurrent event strategy in randomised trials

Fuente: arXiv
Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hindley, Joanna, Hartley, Charlotte, Hellier, Jennifer, Sturgeon, Kate, Greenwood, Sophie, Newsome, Ian, Barrett, Katherine, Smith, Debs, Pham, Tra My, Bi, Dongquan, Goulao, Beatriz, Cro, Suzie, Kahan, Brennan C
Format: Preprint
Veröffentlicht: 2026
Schlagworte:
Online-Zugang:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1866909990326894592
author Hindley, Joanna
Hartley, Charlotte
Hellier, Jennifer
Sturgeon, Kate
Greenwood, Sophie
Newsome, Ian
Barrett, Katherine
Smith, Debs
Pham, Tra My
Bi, Dongquan
Goulao, Beatriz
Cro, Suzie
Kahan, Brennan C
author_facet Hindley, Joanna
Hartley, Charlotte
Hellier, Jennifer
Sturgeon, Kate
Greenwood, Sophie
Newsome, Ian
Barrett, Katherine
Smith, Debs
Pham, Tra My
Bi, Dongquan
Goulao, Beatriz
Cro, Suzie
Kahan, Brennan C
contents Estimands can help to clarify the research questions being addressed in randomised trials. Because the choice of estimand can affect how relevant trial results are to patients and other stakeholders, such as clinicians or policymakers, it is important for them to be involved in these decisions. However, there are barriers to having these conversations. For instance, discussions around how intercurrent events should be addressed in the estimand definition typically involve complex concepts as well as technical language. We three tools to facilitate conversations between researchers and patients and other stakeholders about the choice of estimand and intercurrent event strategy: (i) a video explaining the concept of an estimand and the five different ways that intercurrent events can be incorporated into the estimand definition; (ii) an infographic outlining these five strategies; and (iii) an editable PowerPoint slide which can be completed with trial-specific details to facilitate conversations around choice of estimand for a particular trial. These resources can help to start conversations between the trial team and patients and other stakeholders about the best choice of estimand and intercurrent event strategies for a randomised trial.
format Preprint
id arxiv_https___arxiv_org_abs_2601_09442
institution arXiv
publishDate 2026
record_format arxiv
spellingShingle Tools to help patients and other stakeholders' input into choice of estimand and intercurrent event strategy in randomised trials
Hindley, Joanna
Hartley, Charlotte
Hellier, Jennifer
Sturgeon, Kate
Greenwood, Sophie
Newsome, Ian
Barrett, Katherine
Smith, Debs
Pham, Tra My
Bi, Dongquan
Goulao, Beatriz
Cro, Suzie
Kahan, Brennan C
Methodology
Estimands can help to clarify the research questions being addressed in randomised trials. Because the choice of estimand can affect how relevant trial results are to patients and other stakeholders, such as clinicians or policymakers, it is important for them to be involved in these decisions. However, there are barriers to having these conversations. For instance, discussions around how intercurrent events should be addressed in the estimand definition typically involve complex concepts as well as technical language. We three tools to facilitate conversations between researchers and patients and other stakeholders about the choice of estimand and intercurrent event strategy: (i) a video explaining the concept of an estimand and the five different ways that intercurrent events can be incorporated into the estimand definition; (ii) an infographic outlining these five strategies; and (iii) an editable PowerPoint slide which can be completed with trial-specific details to facilitate conversations around choice of estimand for a particular trial. These resources can help to start conversations between the trial team and patients and other stakeholders about the best choice of estimand and intercurrent event strategies for a randomised trial.
title Tools to help patients and other stakeholders' input into choice of estimand and intercurrent event strategy in randomised trials
topic Methodology
url https://arxiv.org/abs/2601.09442